Anandamide and Δ9-tetrahydrocannabinol directly inhibit cells of the immune system via CB2 receptors

This publication has 38 references indexed in Scilit:

• Cannabinoid Treatment Suppresses the T-Helper Cell-Polarizing Function of Mouse Dendritic Cells Stimulated with Legionella pneumophila Infection
  The Journal of Pharmacology and Experimental Therapeutics, 2006
• Activation through Cannabinoid Receptors 1 and 2 on Dendritic Cells Triggers NF-κB-Dependent Apoptosis: Novel Role for Endogenous and Exogenous Cannabinoids in Immunoregulation
  The Journal of Immunology, 2004
• Anandamide is an endogenous inhibitor for the migration of tumor cells and T lymphocytes
  Cancer Immunology, Immunotherapy, 2004
• Pharmacological characterisation of cannabinoid receptors inhibiting interleukin 2 release from human peripheral blood mononuclear cells
  European Journal of Pharmacology, 2003
• Cannabinol Enhancement of Interleukin-2 (IL-2) Expression by T Cells Is Associated with an Increase in IL-2 Distal Nuclear Factor of Activated T Cell Activity
  Molecular Pharmacology, 2002
• Differential expression of the CB2 cannabinoid receptor by rodent macrophages and macrophage-like cells in relation to cell activation
  International Immunopharmacology, 2001
• Inhibitory effects of SR141716A on G-protein activation in rat brain
  European Journal of Pharmacology, 2001
• Effects of cannabinoids on LPS‐stimulated inflammatory mediator release from macrophages: Involvement of eicosanoids
  Journal of Cellular Biochemistry, 2001
• Anandamide Induces Apoptosis in Human Cells via Vanilloid Receptors
  Journal of Biological Chemistry, 2000
• Genomic and Functional Changes Induced by the Activation of the Peripheral Cannabinoid Receptor CB2 in the Promyelocytic Cells HL-60
  Journal of Biological Chemistry, 2000